EuroPCR 2009 Webcast:

EuroPCR 2009 Webcast: New Techniques for the Treatment of Bifurcation Lesions See the video

Tryton Announces Events at European Bifurcation Club Meeting

Dateline City: DURHAM, N.C. Leading Cardiologists will Discuss Experience with Tryton Stent System DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company’s TRYTON Side Branch Stent™ System will be featured in discussions by a number of leading cardiologists in a symposium on Oct. 16, 2009, in conjunction with …

Tryton Medical, Inc. Broadcasts Successful Live Case Using Company's Side Branch Stent™ to Definitively Treat Bifurcation Lesions at TCT 2009 More than 1,000 Clinicians Observe Implantation of Unique Stent System for Difficult-to-Treat Coronary Artery Disease

September 24, 2009: Tryton Medical, Inc. Broadcasts Successful Live Case Using Company’s Side Branch Stent™ to Definitively Treat Bifurcation Lesions at TCT 2009 More than 1,000 Clinicians Observe Implantation of Unique Stent System for Difficult-to-Treat Coronary Artery Disease Download PDF

Tryton Medical, Inc. Broadcasts Successful Live Case Using Company’s Side Branch Stent™ to Definitively Treat Bifurcation Lesions at TCT 2009

Dateline City: DURHAM, N.C. & San Francisco More than 1,000 Clinicians Observe Implantation of Unique Stent System for Difficult-to-Treat Coronary Artery Disease DURHAM, N.C. & San Francisco–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today the transmission of a live satellite feed of a clinical case performed in the United Kingdom to …

Tryton Awarded Patent for Innovative Side Branch Stent System

Dateline City: DURHAM, N.C. Patent Award Recognizes Unique Technology DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company’s Tryton Side Branch Stent™ System. The Tryton Side Branch Stent offers a dedicated strategy for treating atherosclerotic lesions at a bifurcation. These lesions …